TLIS   $0.65  0.57% Market Closed

Talis Biomedical Corp
Total Cash 59.87M
totalCashPerShare 32.843
EBITDA -45.58M
Total Debt 18.80M
quickRatio 7.304
currentRatio 7.76
Total Revenue 408.00K
debtToEquity 38.662
Revenue/Share 0.224
ROA -0.29594
ROE -0.70482004
grossProfits
freeCashflow -25.91M
operatingCashflow -40.26M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -113.602936
profitMargins 0.0
enterpriseValue -37.87M
forwardPE
floatShares 765.11K
sharesOutstanding 1.82M
sharesShort 17.96K
sharesShortPriorMonth 14.00K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.53%
Short Ratio help_outline 0.59%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 26.684
Price To Book help_outline 0.07
earningsQuarterlyGrowth
netIncomeToCommon -51.03M
trailingEps -28.02%
forwardEps -23.32%
enterpriseToEbitda 0.83
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount 21
lastUpdated Oct. 16, 2024, 11:49 p.m.